Sentence: The primary endpoint of this study was to determine the maximal tolerated dose of the combination of dose-escalating curcumin and standard dose of docetaxel chemotherapy in advanced and metastatic breast cancer patients .
Drug combination annotation:
[{'class': 'POS', 'spans': ['curcumin', 'docetaxel'], 'is_context_needed': False}]